| AF | atrial fibrillation |
| DOAC | direct oral anticoagulant |
| HF | heart failure |
| LVEF | left ventricular ejection fraction |
| PAD | peripheral artery disease |
| VKA | vitamin K antagonist |
| AF | atrial fibrillation |
| DOAC | direct oral anticoagulant |
| HF | heart failure |
| LVEF | left ventricular ejection fraction |
| PAD | peripheral artery disease |
| VKA | vitamin K antagonist |